Excess O-GlcNAc modification of proteins and myocardial fibrosis

蛋白质的过量 O-GlcNAc 修饰与心肌纤维化

基本信息

项目摘要

The major hypothesis to be tested in this proposal is that, “Reducing the excess addition of β-N- acetylglucosamine (O-GlcNAc) to regulatory factors present in cardiac fibroblasts ameliorates diabetes mellitus induced myocardial fibrosis”. Given the older average age of the Veteran population, about 25% suffer from type 2 diabetes mellitus (DM2). A large number of these patients will develop DM2 induced cardiac fibrosis, which adversely impacts diastolic function and frequently leads to the development of heart failure. Excess O- GlcNAc modification of proteins is known to occur with aging and most notably in the setting of DM2. We have demonstrated that excess O-GlcNAcylation of cardiac fibroblast (CF) proteins is associated with the enhanced production of collagens. As tissue fibrosis (e.g. glomerulosclerosis) is a prominent feature of DM2 our research findings may also have broader implications as a strategy to ameliorate excess collagen production by fibroblasts present in other organs. The post-translational modification of serine and threonine residues of nuclear and cytoplasmic proteins by the O-linked attachment of the monosaccharide β-N-acetylglucosamine is a highly dynamic and ubiquitous protein modification that is secondary to the action of β-N- acetylglucosaminyltransferase (OGT). Conversely, the removal of O-GlcNAc is mediated by N- acetylglucosaminidase (O-GlcNAcase). Protein O-GlcNAcylation is rapidly emerging as a key regulator of critical biological processes including nuclear transport, translation and transcription, signal transduction, cytoskeletal reorganization, proteasomal degradation, and apoptosis. We demonstrated that in high glucose treated CF, the nuclear transcription factor Sp1 and arginase evidence excess O-GlcNAcylation. Both of these proteins are intricately associated with stimulating the production of collagens. Expression in CF of an adenovirus coding for O-GlcNAcase, decreased Sp1 and arginase O-GlcNAcylation and restores high glucose- induced excess collagen production back to normal levels. However, no studies have identified which specific amino acid residues can be modified by O-GlcNAcylation and how they alter Sp1 and arginase function. Furthermore, these observations have not been evidenced in the in vivo setting and linked with changes in cardiac structure and function. Given these facts and the preliminary data we have generated, we propose to examine the following specific aims: Aim 1. To identify the development of myocardial fibrosis, diastolic dysfunction, Sp1 and arginase I residue modification in an aged model of DM2. Aim 2. To characterize HG induced CF amino acid residue O-GlcNAc modification of Sp1 and arginase I and its functional implications. Aim 3. To characterize the capacity of altered O-GlcNAcase activity to modify DM2 or HG induced alterations in Sp1 and arginase I residue modification, fibroblast/myofibroblast phenotype, cardiac structure and function.
该提议中要检验的主要假设是,“减少了β-n-的过量添加 乙酰葡萄糖(O-GLCNAC)对心脏成纤维细胞中存在的调节因子可改善糖尿病 诱发心肌纤维化”。鉴于老兵的年龄较大,大约25%的人患有 2型糖尿病(DM2)。这些患者中有大量会出现DM2诱导的心脏纤维化, 这会对舒张功能产生不利影响,并经常导致心力衰竭的发展。多余的O- 已知蛋白质的GlcNAC修饰是随着衰老而发生的,最著名的是在DM2的情况下发生。我们有 证明心脏成纤维细胞(CF)蛋白的O-Glcnacylation与增强 生产胶原蛋白。由于组织纤维化(例如肾小球硬化)是DM2的重要特征。 调查结果也可能具有更广泛的含义,以减轻通过 其他器官中存在的成纤维细胞。丝氨酸和苏氨酸保留的翻译后修饰 单糖β-N-乙酰葡萄糖的O连接附着的核和细胞质蛋白是 高度动态和普遍存在的蛋白质修饰,是β-n-作用的继发的 乙酰氨基氨基链酰酯转移酶(OGT)。相反,去除O-GlCNAC是由N-介导的 乙酰葡萄糖氨基酶(O-GlcNACASE)。蛋白O-Glcnacylation迅速成为一个关键调节剂 关键的生物学过程,包括核转运,翻译和转录,信号转导, 细胞骨架重组,蛋白酶体降解和凋亡。我们证明了在高葡萄糖中 处理过的CF,核转录因子SP1和精氨酸酶证据超过O-Glcnacylation。这两个 蛋白质与刺激胶原蛋白的产生相关。在CF中的表达 编码O-Glcnacase的腺病毒,SP1和精氨酸酶O-Glcnacylation降低并恢复高葡萄糖 - 诱导过多的胶原蛋白产生回到正常水平。但是,尚未确定哪个特定 氨基酸残基可以通过O-Glcnacylation以及它们如何改变SP1和精氨酸酶功能来改变。 此外,这些观察结果尚未在体内环境中得到证明,并与变化有关 心脏结构和功能。鉴于这些事实和我们生成的初步数据,我们建议 检查以下特定目的:目标1。确定心肌纤维化的发展 DM2老化模型中的功能障碍,SP1和精氨酸酶I的住所修饰。目标2。表征HG 诱导的CF氨基酸保留O-GLCNAC对SP1和精氨酸酶I及其功能意义的修饰。 目标3。表征改变O-Glcnacase活性改变DM2或HG诱导改变的能力 在SP1和精氨酸酶I修饰中,成纤维细胞/成肌纤维细胞表型,心脏结构和功能。

项目成果

期刊论文数量(12)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
In Pursuit of Understanding the Role of Estrogens in Regulating Cardiac Structure and Function.
Restorative potential of (-)-epicatechin in a rat model of Gulf War illness muscle atrophy and fatigue.
  • DOI:
    10.1038/s41598-021-01093-w
  • 发表时间:
    2021-11-08
  • 期刊:
  • 影响因子:
    4.6
  • 作者:
    Ramirez-Sanchez I;Navarrete-Yañez V;Garate-Carrillo A;Lara-Hernandez M;Espinosa-Raya J;Moreno-Ulloa A;Gomez-Diaz B;Cedeño-Garcidueñas AL;Ceballos G;Villarreal F
  • 通讯作者:
    Villarreal F
Development of muscle atrophy and loss of function in a Gulf-War illness model: underlying mechanisms.
海湾战争疾病模型中肌肉萎缩和功能丧失的发展:潜在机制。
  • DOI:
    10.1038/s41598-020-71486-w
  • 发表时间:
    2020
  • 期刊:
  • 影响因子:
    4.6
  • 作者:
    Ramirez-Sanchez,Israel;Navarrete-Yañez,Viridiana;Garate-Carrillo,Alejandra;Loredo,Maria;Lira-Romero,Esmeralda;Estrada-Mena,Javier;Campeau,Anaamika;Gonzalez,David;Carrillo-Terrazas,Marvic;Moreno-Ulloa,Aldo;Ceballos,Guillermo;Villarrea
  • 通讯作者:
    Villarrea
Multi-omics study identifies novel signatures of DNA/RNA, amino acid, peptide, and lipid metabolism by simulated diabetes on coronary endothelial cells.
  • DOI:
    10.1038/s41598-022-16300-5
  • 发表时间:
    2022-07-14
  • 期刊:
  • 影响因子:
    4.6
  • 作者:
    Moreno-Ulloa, Aldo;Delgado-De la Herran, Hilda Carolina;Alvarez-Delgado, Carolina;Mendoza-Porras, Omar;Carballo-Castaneda, Rommel A.;Donis-Maturano, Luis;Villarreal, Francisco
  • 通讯作者:
    Villarreal, Francisco
Sex related differences in the pathogenesis of organ fibrosis.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Francisco J Villarreal其他文献

Francisco J Villarreal的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Francisco J Villarreal', 18)}}的其他基金

Beneficial Effects of FPR Agonists on an Animal Model of Early Stage Heart Failure with Preserved Ejection Fraction
FPR 激动剂对射血分数保留的早期心力衰竭动物模型的有益作用
  • 批准号:
    10580246
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Targeting cellular bioenergetics for the prevention and treatment of diabetes
针对细胞生物能量学预防和治疗糖尿病
  • 批准号:
    8150760
  • 财政年份:
    2011
  • 资助金额:
    --
  • 项目类别:
Effects of Cocoa Flavonols on Myocardial Infarction Size and Post-Injury Injury
可可黄酮醇对心肌梗死面积和损伤后损伤的影响
  • 批准号:
    7921723
  • 财政年份:
    2008
  • 资助金额:
    --
  • 项目类别:
Effects of Cocoa Flavonols on Myocardial Infarction Size and Post-Injury Injury
可可黄酮醇对心肌梗死面积和损伤后损伤的影响
  • 批准号:
    7534759
  • 财政年份:
    2008
  • 资助金额:
    --
  • 项目类别:
Effects of Cocoa Flavonols on Myocardial Infarction Size and Post-Injury Injury
可可黄酮醇对心肌梗死面积和损伤后损伤的影响
  • 批准号:
    7694384
  • 财政年份:
    2008
  • 资助金额:
    --
  • 项目类别:
26th Annual Meeting of the North Am. Section of the ISHR
第26届北美年会。
  • 批准号:
    6837277
  • 财政年份:
    2004
  • 资助金额:
    --
  • 项目类别:
Adenosine Mediated Modulation of Cardiac Fibrosis
腺苷介导的心脏纤维化调节
  • 批准号:
    6895818
  • 财政年份:
    2002
  • 资助金额:
    --
  • 项目类别:
Adenosine Mediated Modulation of Cardiac Fibrosis
腺苷介导的心脏纤维化调节
  • 批准号:
    6612815
  • 财政年份:
    2002
  • 资助金额:
    --
  • 项目类别:
Adenosine Mediated Modulation of Cardiac Fibrosis
腺苷介导的心脏纤维化调节
  • 批准号:
    6758583
  • 财政年份:
    2002
  • 资助金额:
    --
  • 项目类别:
Adenosine Mediated Modulation of Cardiac Fibrosis
腺苷介导的心脏纤维化调节
  • 批准号:
    6542064
  • 财政年份:
    2002
  • 资助金额:
    --
  • 项目类别:

相似国自然基金

肝胆肿瘤治疗性溶瘤腺病毒疫苗的研制及其临床前应用性探索
  • 批准号:
    82303776
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
PD-1/PD-L1信号促CD21-B细胞BCR髓外二次编辑降低自身反应性在儿童腺病毒肺炎中的作用机制研究
  • 批准号:
    82370015
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
基于sIgA的V(D)J结构多样性探索腺病毒载体鼻喷新冠奥密克戎疫苗诱导的呼吸道粘膜免疫原性特征
  • 批准号:
    82302607
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
禽腺病毒血清11型反向遗传平台的建立与毒株间致病性差异机制探究
  • 批准号:
    32372997
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
CD46和DSG2双受体在人B组腺病毒感染与致病中的协同作用和机制研究
  • 批准号:
    32370155
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目

相似海外基金

A Novel Vector Strategy to Feasibilize Cellular Therapy for Heart Disease
一种使心脏病细胞治疗变得可行的新型载体策略
  • 批准号:
    10746971
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Induction of Cardiomyocyte Proliferation via Transient Expression of Cell Cycle Factors as a Promising Therapy for Heart Failure
通过细胞周期因子的瞬时表达诱导心肌细胞增殖作为心力衰竭的一种有前景的治疗方法
  • 批准号:
    10365990
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
Novel combined immunotherapeutic strategies for glioma: using pet dogs as a large animal spontaneous model
胶质瘤联合免疫治疗新策略:使用宠物狗作为大型动物自发模型
  • 批准号:
    9449905
  • 财政年份:
    2017
  • 资助金额:
    --
  • 项目类别:
CMV pentameric complex based vaccine strategies for prevention of congenital CMV
基于 CMV 五聚体复合物的预防先天性 CMV 的疫苗策略
  • 批准号:
    9382991
  • 财政年份:
    2017
  • 资助金额:
    --
  • 项目类别:
The role of circulating Slit2 in adipose thermogenesis and diabetes
循环 Slit2 在脂肪产热和糖尿病中的作用
  • 批准号:
    9349495
  • 财政年份:
    2016
  • 资助金额:
    --
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了